TR201914043A1 - EFERVESAN TABLET FORMULATIONS CONTAINING DAPAGLYFLOZIN AND METFORMIN - Google Patents

EFERVESAN TABLET FORMULATIONS CONTAINING DAPAGLYFLOZIN AND METFORMIN

Info

Publication number
TR201914043A1
TR201914043A1 TR2019/14043A TR201914043A TR201914043A1 TR 201914043 A1 TR201914043 A1 TR 201914043A1 TR 2019/14043 A TR2019/14043 A TR 2019/14043A TR 201914043 A TR201914043 A TR 201914043A TR 201914043 A1 TR201914043 A1 TR 201914043A1
Authority
TR
Turkey
Prior art keywords
metformin
efervesan
dapaglyflozin
tablet formulations
formulations containing
Prior art date
Application number
TR2019/14043A
Other languages
Turkish (tr)
Inventor
Ulusoy Bozyel Müge
Dedeoğlu Yavuz
Taşkin Abdullah
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2019/14043A priority Critical patent/TR201914043A1/en
Priority to EP20866500.0A priority patent/EP4031122A4/en
Priority to PCT/TR2020/050687 priority patent/WO2021054912A1/en
Publication of TR201914043A1 publication Critical patent/TR201914043A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Abstract

Buluş, dapagliflozin veya dapagliflozinin farmasötik olarak kabul edilebilir bir tuzu ve metformin veya metforminin farmasötik olarak kabul edilebilir bir tuzu ile gerçekleştirilen efervesan tablet formülasyonlar ile ilgilidir.The invention relates to effervescent tablet formulations made with dapagliflozin or a pharmaceutically acceptable salt of dapagliflozin and metformin or a pharmaceutically acceptable salt of metformin.

TR2019/14043A 2019-09-16 2019-09-16 EFERVESAN TABLET FORMULATIONS CONTAINING DAPAGLYFLOZIN AND METFORMIN TR201914043A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2019/14043A TR201914043A1 (en) 2019-09-16 2019-09-16 EFERVESAN TABLET FORMULATIONS CONTAINING DAPAGLYFLOZIN AND METFORMIN
EP20866500.0A EP4031122A4 (en) 2019-09-16 2020-08-05 Effervescent tablet formulations comprising dapagliflozin and metformin
PCT/TR2020/050687 WO2021054912A1 (en) 2019-09-16 2020-08-05 Effervescent tablet formulations comprising dapagliflozin and metformin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/14043A TR201914043A1 (en) 2019-09-16 2019-09-16 EFERVESAN TABLET FORMULATIONS CONTAINING DAPAGLYFLOZIN AND METFORMIN

Publications (1)

Publication Number Publication Date
TR201914043A1 true TR201914043A1 (en) 2021-04-21

Family

ID=74883168

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/14043A TR201914043A1 (en) 2019-09-16 2019-09-16 EFERVESAN TABLET FORMULATIONS CONTAINING DAPAGLYFLOZIN AND METFORMIN

Country Status (3)

Country Link
EP (1) EP4031122A4 (en)
TR (1) TR201914043A1 (en)
WO (1) WO2021054912A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4079296A1 (en) * 2021-04-21 2022-10-26 Sanovel Ilac Sanayi Ve Ticaret A.S. A bilayer tablet formulation comprising amorphous dapagliflozin and metformin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1945190A1 (en) * 2005-09-22 2008-07-23 Swissco Devcelopment AG Effervescent metformin composition and tablets and granules made therefrom
HUE040486T2 (en) 2009-11-13 2019-03-28 Astrazeneca Ab Bilayer tablet formulations
EP2809311A1 (en) * 2012-01-31 2014-12-10 Mahmut Bilgic Effervescent tablet formulations comprising the combination of voglibose and metformin
WO2017098481A1 (en) * 2015-12-12 2017-06-15 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
WO2018185669A1 (en) 2017-04-07 2018-10-11 Zenvision Pharma Llp Effervescent compositions comprising saxagliptin or salt thereof

Also Published As

Publication number Publication date
EP4031122A1 (en) 2022-07-27
WO2021054912A1 (en) 2021-03-25
EP4031122A4 (en) 2023-08-30

Similar Documents

Publication Publication Date Title
TR201916829A2 (en) DUAL-LAYER TABLET FORMULATIONS CONTAINING DAPAGLYFLOZIN AND METFORMIN
CR20220070A (en) Parp1 inhibitors
ECSP20025899A (en) COMPOUNDS USEFUL TO INHIBIT CDK7
PH12018500047B1 (en) Notch pathway signaling inhibitor compounds
PH12019550249A1 (en) Solid compositions for oral administration
MX2017016802A (en) Pharmaceutical formulations.
MX2020005483A (en) Ildr2 antagonists and combinations thereof.
MX2020010697A (en) Kit, composition and combination therapy for fragile x syndrome.
ZA202006377B (en) Boronic acid derivatives and therapeutic uses thereof
EA202090542A1 (en) HIGHLY CONCENTRATED MEDICINAL FORMS OF Pridopidine
CL2020002199A1 (en) Methylactam ring compound and pharmaceutical use thereof.
TR201914043A1 (en) EFERVESAN TABLET FORMULATIONS CONTAINING DAPAGLYFLOZIN AND METFORMIN
GEP20237486B (en) Formulations of copanlisib
PH12018501758A1 (en) Oritavancin formulations
PH12020551985A1 (en) Anti-human tlr7 antibody
TR201913472A2 (en) A combination comprising vildagliptin and metformin
MX2021003830A (en) Therapeutic uses of glucagon and combined product comprising same.
TR201721700A2 (en) DISTRIBUTED FORMULATIONS OF SAXAGLIPT IN THE MOUTH
TR201722367A2 (en) PHARMACEUTICAL COMPOSITIONS FOR PARENTERAL APPLICATION CONTAINING LACOSAMIDE
TR201713954A2 (en) PHARMACEUTICAL COMBINATIONS OF TENOFOVIR, EMTRISITABIN AND EAVIRENZINE
BR112022012584A2 (en) SUBSTITUTED HYDROXYSTIBENE COMPOUNDS AND DERIVATIVES, SYNTHESIS AND USE OF THEM
TR201914406A2 (en) SOLID ORAL PHARMACEUTICAL FORMULATIONS CONTAINING SAPROPTERIN DIHYDROCHLORIDE AND AT LEAST ONE PHARMACEUTICAL EXCIPIENT
EA201691422A1 (en) ORIGINALLY FALLING TABLETED MEMANTINE COMPOSITIONS
TR201914416A1 (en) Effervescent formulations of sapropterin dihydrochloride
TR201721824A2 (en) A MODIFIED EMISSION COMBINATION CONTAINING LINAGLIPTIN AND METFORMIN